BPO
Click for more information
0.00% 0.3¢ bioprospect limited

its only a matter of time, page-2

  1. HogesNT
    1,454 Posts.
    clock Created with Sketch.
    09/05/09
    10:21
    Post #: 5114223
    You would think the BioProspect deal to purchase Re-Gen is a sign of BPO getting confident about relevant approvals for TERMILONE and its commercial release of the product in the next year or so - all around the world - that may see the value of the company grow substantially you would think

    Hoges
    BPO Price at posting: 1.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.